Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer - PubMed (original) (raw)

Clinical Trial

. 2005 Nov;11(11):1230-7.

doi: 10.1038/nm1310. Epub 2005 Oct 16.

Edward A Stadtmauer, Nicole Aqui, Ashraf Badros, Julio Cotte, Lisa Chrisley, Elizabeth Veloso, Zhaohui Zheng, Sandra Westphal, Rebecca Mair, Nina Chi, Bashi Ratterree, Mary Francis Pochran, Sabrina Natt, Joanne Hinkle, Cheryl Sickles, Ambika Sohal, Kathleen Ruehle, Christian Lynch, Lei Zhang, David L Porter, Selina Luger, Chuanfa Guo, Hong-Bin Fang, William Blackwelder, Kim Hankey, Dean Mann, Robert Edelman, Carl Frasch, Bruce L Levine, Alan Cross, Carl H June

Affiliations

• PMID: 16227990
• DOI: 10.1038/nm1310

Clinical Trial

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

Aaron P Rapoport et al. Nat Med. 2005 Nov.

Abstract

Immunodeficiency is a barrier to successful vaccination in individuals with cancer and chronic infection. We performed a randomized phase 1/2 study in lymphopenic individuals after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for myeloma. Combination immunotherapy consisting of a single early post-transplant infusion of in vivo vaccine-primed and ex vivo costimulated autologous T cells followed by post-transplant booster immunizations improved the severe immunodeficiency associated with high-dose chemotherapy and led to the induction of clinically relevant immunity in adults within a month after transplantation. Immune assays showed accelerated restoration of CD4 T-cell numbers and function. Early T-cell infusions also resulted in significantly improved T-cell proliferation in response to antigens that were not contained in the vaccine, as assessed by responses to staphylococcal enterotoxin B and cytomegalovirus antigens (P < 0.05). In the setting of lymphopenia, combined vaccine therapy and adoptive T-cell transfer fosters the development of enhanced memory T-cell responses.

PubMed Disclaimer

Comment in

• Vaccinating transplant recipients.
  Molldrem JJ. Molldrem JJ. Nat Med. 2005 Nov;11(11):1162-3. doi: 10.1038/nm1105-1162. Nat Med. 2005. PMID: 16270072 No abstract available.

Similar articles

• Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.
  Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Fang HB, Cai L, Janofsky S, Chew A, Storek J, Akpek G, Badros A, Yanovich S, Tan MT, Veloso E, Pasetti MF, Cross A, Philip S, Murphy H, Bhagat R, Zheng Z, Milliron T, Cotte J, Cannon A, Levine BL, Vonderheide RH, June CH. Rapoport AP, et al. Blood. 2011 Jan 20;117(3):788-97. doi: 10.1182/blood-2010-08-299396. Epub 2010 Oct 28. Blood. 2011. PMID: 21030558 Free PMC article. Clinical Trial.
• Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
  Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, Philip S, Kerr N, Brennan A, Zheng Z, Ruehle K, Milliron T, Strome SE, Salazar AM, Levine BL, June CH. Rapoport AP, et al. Clin Cancer Res. 2014 Mar 1;20(5):1355-65. doi: 10.1158/1078-0432.CCR-13-2817. Epub 2014 Feb 11. Clin Cancer Res. 2014. PMID: 24520093 Free PMC article. Clinical Trial.
• Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
  Rapoport AP, Stadtmauer EA, Aqui N, Vogl D, Chew A, Fang HB, Janofsky S, Yager K, Veloso E, Zheng Z, Milliron T, Westphal S, Cotte J, Huynh H, Cannon A, Yanovich S, Akpek G, Tan M, Virts K, Ruehle K, Harris C, Philip S, Vonderheide RH, Levine BL, June CH. Rapoport AP, et al. Clin Cancer Res. 2009 Jul 1;15(13):4499-507. doi: 10.1158/1078-0432.CCR-09-0418. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509133 Free PMC article. Clinical Trial.
• T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!
  Porter DL, June CH. Porter DL, et al. Bone Marrow Transplant. 2005 May;35(10):935-42. doi: 10.1038/sj.bmt.1704953. Bone Marrow Transplant. 2005. PMID: 15806121 Review.
• Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come.
  Rapoport AP. Rapoport AP. Bone Marrow Transplant. 2006 Feb;37(3):239-47. doi: 10.1038/sj.bmt.1705242. Bone Marrow Transplant. 2006. PMID: 16327812 Review.

Cited by

• CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies.
  Louie RHY, Cai C, Samir J, Singh M, Deveson IW, Ferguson JM, Amos TG, McGuire HM, Gowrishankar K, Adikari T, Balderas R, Bonomi M, Ruella M, Bishop D, Gottlieb D, Blyth E, Micklethwaite K, Luciani F. Louie RHY, et al. Nat Commun. 2023 Nov 27;14(1):7767. doi: 10.1038/s41467-023-43656-7. Nat Commun. 2023. PMID: 38012187 Free PMC article.
• Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
  Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Somaiya Dutt P, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D. Chung DJ, et al. Clin Cancer Res. 2023 Dec 1;29(23):4784-4796. doi: 10.1158/1078-0432.CCR-23-0235. Clin Cancer Res. 2023. PMID: 37463058 Free PMC article. Clinical Trial.
• Highlights into historical and current immune interventions for cancer.
  Cole K, Al-Kadhimi Z, Talmadge JE. Cole K, et al. Int Immunopharmacol. 2023 Apr;117:109882. doi: 10.1016/j.intimp.2023.109882. Epub 2023 Feb 27. Int Immunopharmacol. 2023. PMID: 36848790 Free PMC article. Review.
• It takes T to tango: immunotherapy in MM.
  Gupta VA, Dhodapkar MV. Gupta VA, et al. Blood. 2022 Mar 3;139(9):1259-1260. doi: 10.1182/blood.2021013816. Blood. 2022. PMID: 35238890 Free PMC article. No abstract available.
• Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
  Verheye E, Bravo Melgar J, Deschoemaeker S, Raes G, Maes A, De Bruyne E, Menu E, Vanderkerken K, Laoui D, De Veirman K. Verheye E, et al. Int J Mol Sci. 2022 Jan 14;23(2):904. doi: 10.3390/ijms23020904. Int J Mol Sci. 2022. PMID: 35055096 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program